Wühl Elke, Kogan Jillene, Zurowska Aleksandra, Matejas Verena, Vandevoorde Rene G, Aigner Thomas, Wendler Olaf, Lesniewska Iga, Bouvier Raymonde, Reis André, Weis Joachim, Cochat Pierre, Zenker Martin
Department of Pediatric Nephrology, University Children's Hospital, Heidelberg, Germany.
Am J Med Genet A. 2007 Feb 15;143(4):311-9. doi: 10.1002/ajmg.a.31564.
Pierson syndrome is an autosomal recessive disorder comprising congenital nephrotic syndrome with diffuse mesangial sclerosis and distinct eye abnormalities with microcoria reported as the most prominent clinical feature. LAMB2 mutations leading to lack of laminin beta2 were identified as the molecular cause underlying Pierson syndrome. Although LAMB2 is known to be expressed in the neuromuscular system, and defects of the neuromuscular junctions had been found in laminin beta2-deficient mice, no consistent neurological phenotype has been described clinically in murine or human laminin beta2-deficiency before. This is likely due to the early lethality from renal failure. Here we provide a detailed description of neurological manifestations and development in four patients affected by Pierson syndrome, who survived until the age of 1.3-4.8 years owing to renal replacement therapy. Severe muscular hypotonia, psychomotor retardation, and blindness were present in three patients harboring truncating mutations on both LAMB2 alleles. These symptoms were not attributable to complications of chronic renal failure, thus representing a primary feature of the genetic disorder. Alterations in skeletal muscle tissue from one case were compatible with a chronic denervating process. One affected girl, however, exhibited a milder course of renal disease, normal development, and preserved vision, presumably owing to some residual LAMB2 function. Our findings indicate that severe neurodevelopmental deficits have to be considered as part of Pierson syndrome, at least in the presence of biallelic functional null mutations (complete lack of laminin beta2). This is an important issue in the counseling of parents of an affected newborn or infant.
皮尔逊综合征是一种常染色体隐性疾病,其特征包括先天性肾病综合征伴弥漫性系膜硬化以及明显的眼部异常,其中小瞳孔被报道为最突出的临床特征。导致层粘连蛋白β2缺乏的LAMB2突变被确定为皮尔逊综合征的分子病因。尽管已知LAMB2在神经肌肉系统中表达,并且在层粘连蛋白β2缺陷小鼠中发现了神经肌肉接头缺陷,但此前在小鼠或人类层粘连蛋白β2缺乏症中尚未有一致的临床神经学表型描述。这可能是由于肾衰竭导致的早期致死率。在此,我们详细描述了4例受皮尔逊综合征影响的患者的神经学表现和发育情况,这些患者由于肾脏替代治疗存活至1.3 - 4.8岁。3例携带LAMB2两个等位基因截断突变的患者出现严重的肌张力减退、精神运动发育迟缓及失明。这些症状并非慢性肾衰竭的并发症所致,因此代表了该遗传性疾病的主要特征。1例患者骨骼肌组织的改变与慢性去神经支配过程相符。然而,1例受影响女孩的肾病病程较轻,发育正常且视力保留,推测是由于LAMB2仍有一些残余功能。我们的研究结果表明,至少在存在双等位基因功能无效突变(层粘连蛋白β2完全缺乏)的情况下,严重的神经发育缺陷应被视为皮尔逊综合征的一部分。这在为受影响新生儿或婴儿的父母提供咨询时是一个重要问题。